AmerisourceBergen
OverviewSuggest Edit
AmerisourceBergen is a pharmaceutical services company serving global markets with a focus on the pharmaceutical supply chain. Servicing both pharmaceutical manufacturers and healthcare providers, The Company provides drug distribution and related services designed to reduce costs and improve patient outcomes.
| Type | Public | |
| Founded | 2001 | |
| HQ | Wayne, US | Map |
| Website | amerisourcebergen.com | |
| Employee Ratings | More | |
| Culture score | B | More |
Recent NewsAll News
- Amid Opioid Lawsuits, Walgreens Wants Distance From AmerisourceBergen
- Earnings Distortion Makes AmerisourceBergen a Stock to Buy
- McKesson, Cardinal Health, AmerisourceBergen stocks surge after WSJ report of $18 billion settlement talks
- AmerisourceBergen Announces Long-Term Strategic Relationship with OneOncology
Key People/Management at AmerisourceBergen
Steven H. Collis
Chairman, President and Chief Executive Officer
Ornella Barra
Director
Richard W. Gochnauer
Director
Lon R. Greenberg
Director
Michael J. Long
Director
John G. Chou
Executive Vice President, Chief Legal Officer and Secretary
AmerisourceBergen Office Locations
AmerisourceBergen has an office in Wayne
Wayne, US (HQ)
1300 Morris Dr
AmerisourceBergen Financials and Metrics
AmerisourceBergen Revenue
AmerisourceBergen's revenue was reported to be $179.59 b in FY, 2019 which is a 6.9% increase from the previous period.
| USD | |
|---|---|
Revenue (Q1, 2020) | 47.9b |
Gross profit (Q1, 2020) | 1.2b |
Gross profit margin (Q1, 2020), % | 2.6% |
Net income (Q1, 2020) | 187.6m |
EBIT (Q1, 2020) | 263.4m |
Market capitalization (22-May-2020) | 18.9b |
Closing stock price (22-May-2020) | 93.1 |
Cash (31-Mar-2020) | 3.7b |
EV | 19.4b |
AmerisourceBergen's current market capitalization is $18.9 b.
- Source: SEC Filings
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 29.2b | 28.5b | 30.3b | 33.6b | 32.7b | 34.2b | 36.7b | 35.7b | 36.9b | 38.2b | 37.1b | 38.7b | 40.5b | 81.5b | 43.1b | 45.4b | 43.3b | 45.2b | 47.9b |
Cost of goods sold | 28.5b | 27.7b | 29.7b | 32.8b | 31.8b | 33.3b | 35.7b | 34.6b | 35.8b | 37.1b | 35.9b | 37.6b | 39.4b | 79.1b | 41.9b | 44.1b | 41.9b | 44.0b | 46.6b |
Gross profit | 688.2m | 729.6m | 692.0m | 752.3m | 912.0m | 891.5m | 964.9m | 1.1b | 1.1b | 1.0b | 1.3b | 1.1b | 1.1b | 2.4b | 1.2b | 1.3b | 1.4b | 1.2b | 1.2b |
Gross profit Margin, % | 2% | 3% | 2% | 2% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% |
- Source: SEC Filings
Annual
Quarterly
| USD | Q2, 2010 | Q3, 2010 | Q1, 2011 | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 1.2b | 1.3b | 1.4b | 1.9b | 2.0b | 2.4b | 2.3b | 1.7b | 417.4m | 1.3b | 1.6b | 347.5m | 696.7m | 1.3b | 2.3b | 2.3b | 2.6b | 978.1m | 2.5b | 1.9b | 1.8b | 2.4b | 1.3b | 3.0b | 2.1b | 2.4b | 2.5b | 2.9b | 3.0b | 3.2b | 3.7b |
Accounts Receivable | 3.9b | 3.9b | 3.6b | 3.8b | 3.9b | 3.7b | 3.9b | 3.9b | 4.4b | 4.2b | 4.6b | 6.2b | 6.5b | 6.1b | 7.1b | 7.6b | 7.6b | 8.4b | 8.8b | 9.0b | 9.7b | 9.6b | 10.6b | 10.1b | 11.3b | 11.8b | 12.0b | 12.2b | 12.0b | 12.6b | 14.2b |
Prepaid Expenses | 37.8m | 42.9m | 35.2m | 45.6m | 55.9m | 36.6m | 53.6m | 124.2m | 54.3m | 72.7m | 90.9m | 63.9m | 63.6m | 74.3m | 73.6m | 142.4m | 110.3m | 139.0m | 133.2m | 115.0m | 176.7m | 170.2m | 143.0m | 110.2m | 173.4m | 176.5m | 182.6m | 172.6m | 163.8m | 189.2m | 175.4m |
Inventories | 5.0b | 5.1b | 5.4b | 5.2b | 5.2b | 5.8b | 5.4b | 5.4b | 6.0b | 5.7b | 5.9b | 8.6b | 8.5b | 8.4b | 10.6b | 9.5b | 9.6b | 10.9b | 10.6b | 10.5b | 11.4b | 11.3b | 11.7b | 12.0b | 12.9b | 12.1b | 11.8b | 11.4b | 11.2b | 11.7b | 11.1b |
- Source: SEC Filings
Annual
| USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 636.7m | 706.6m | 719.0m | 433.7m | 276.5m | (134.9m) | 145.7b | 364.5m | 1.6b | 854.1m |
Depreciation and Amortization | 82.8m | 104.7m | 141.1m | 170.8m | 432.3m | 510.1m | 497.5m | |||
Inventories | (243.0m) | (272.3m) | (200.1m) | (1.5b) | (431.5m) | (4.9m) | (168.0m) | |||
Accounts Payable | 2.3b | 5.1b | 3.0b | 1.5b | 859.0m | 1.6b |
Quarterly
| USD | Q2, 2010 | Q3, 2010 | Q1, 2011 | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 332.3m | 495.5m | 160.5m | 374.9m | 559.3m | 162.1m | 374.2m | 555.5m | 168.6m | 214.2m | 382.7m | 41.4m | 221.5m | 208.7m | (199.9m) | (713.3m) | (499.2m) | 330.4m | 934.5m | 1.3b | 247.2m | 658.7m | 709.1m | 861.9m | 1.1b | 1.4b | 391.8m | 419.8m | 721.8m | 186.6m | 1.2b |
Depreciation and Amortization | 50.4m | 60.4m | 24.5m | 49.6m | 76.4m | 29.1m | 60.1m | 94.8m | 35.4m | 67.8m | 102.7m | 45.7m | 92.0m | 141.2m | 51.2m | 107.8m | 177.8m | 87.5m | 184.9m | 284.1m | 106.3m | 212.4m | 320.3m | 111.7m | 237.2m | 382.7m | 135.2m | 271.8m | 384.1m | 109.3m | 210.2m |
Inventories | 22.9m | 127.9m | 227.7m | (30.5m) | (55.9m) | 326.7m | 135.3m | 53.4m | (272.4m) | (174.5m) | (399.1m) | (1.6b) | (1.5b) | (1.0b) | (2.1b) | (611.2m) | (700.3m) | (1.1b) | (853.1m) | (675.6m) | (713.6m) | (556.1m) | (829.9m) | (460.1m) | (805.2m) | (51.7m) | (898.8m) | (420.2m) | (280.1m) | (631.0m) | (152.4m) |
Accounts Payable | 247.8m | 351.0m | 877.0m | (59.2m) | 384.4m | 463.9m | 1.5b | 1.4b | 964.7m | 787.0m | 2.4b |
- Source: SEC Filings
| USD | Y, 2020 |
|---|---|
EV/CFO | 19.5 x |
Financial Leverage | 11.3 x |
AmerisourceBergen Operating Metrics
| FY, 2016 | |
|---|---|
Countries | 50 |
Distribution Centers | 26 |
AmerisourceBergen Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| MWI Veterinary Supply | January 12, 2015 | $2.50 b |
| TheraCom | December 31, 2011 | $250 m |
| IntrinsiQ | September 06, 2011 | $35 m |
AmerisourceBergen Revenue Breakdown
AmerisourceBergen revenue breakdown by business segment: 96.2% from Pharmaceutical Distribution and 3.8% from Other
AmerisourceBergen Online and Social Media Presence
4.83k Twitter followers
AmerisourceBergen has 4.83k Twitter Followers. The number of followers has increased 1.6% month over month and increased 4.6% quarter over quarter
AmerisourceBergen's Trends
Twitter Engagement Stats for @Healthcare_ABC
3.3k
Tweets
389
Following
4.8k
Followers
31
Tweets last 30 days
3.6
Avg. likes per Tweet
100%
Tweets with engagement
AmerisourceBergen Company Culture
Overall Culture
B
71/100
CEO Rating
A+
77/100
Compensation
B-
67/100
Diversity
B
71/100
AmerisourceBergen News and Updates
November 11, 2019
Amid Opioid Lawsuits, Walgreens Wants Distance From AmerisourceBergen
Walgreens is taking steps to distance the pharmacy chain from drug wholesalers like AmerisourceBergen as opioid litigation intensifies.
November 04, 2019
Earnings Distortion Makes AmerisourceBergen a Stock to Buy
Understated earnings and cheap valuation give this company a higher chance of beating earnings in the short-term and outperforming the market in the long-term.
October 16, 2019
McKesson, Cardinal Health, AmerisourceBergen stocks surge after WSJ report of $18 billion settlement talks
Shares of McKesson Corp. rallied 5.7% in midday trading Wednesday, enough to pace all of its larger-capitalization health care peers, after The Wall Street Journal reported that the drug distributor, and two others, were in talks to pay $18 billion to settle all litigation brought by state and loca…
July 08, 2019
AmerisourceBergen Announces Long-Term Strategic Relationship with OneOncology
OneOncology and AmerisourceBergen to Support Community Oncology Practices to Provide High-Quality Cancer Care to Patients Across the Nation.read more
January 08, 2019
Safe Rx Announces Availability in AmerisourceBergen
GREENWOOD VILLAGE, Colo., Jan. 8, 2019 /PRNewswire/ -- Safe Rx today announced its product availability in AmerisourceBergen, with merchandising kits available to all AmerisourceBergen California customers. "AmerisourceBergen customers can now easily provide safe storage solutions to...
AmerisourceBergen Frequently Asked Questions
When was AmerisourceBergen founded?
AmerisourceBergen was founded in 2001.
Who are AmerisourceBergen key executives?
AmerisourceBergen's key executives are Steven H. Collis, Ornella Barra and Richard W. Gochnauer.
How many employees does AmerisourceBergen have?
AmerisourceBergen has 20,000 employees.
What is AmerisourceBergen revenue?
Latest AmerisourceBergen annual revenue is $179.6 b.
What is AmerisourceBergen revenue per employee?
Latest AmerisourceBergen revenue per employee is $9 m.
Who are AmerisourceBergen competitors?
Competitors of AmerisourceBergen include Owens & Minor, Henry Schein and Cardinal Health.
Where is AmerisourceBergen headquarters?
AmerisourceBergen headquarters is located at 1300 Morris Dr, Wayne.
Where are AmerisourceBergen offices?
AmerisourceBergen has an office in Wayne.
How many offices does AmerisourceBergen have?
AmerisourceBergen has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies